“For practicing urologists, I think it's important for us to recognize that when it comes to these techniques, even with Rezum, there's a variety of ways of doing them," says Bilal Chughtai, MD.
In this interview, Bilal Chughtai, MD, discusses the implications of his recent publication “Pilot study of ‘less is more’ Rezum for treatment of BPH.” Dr. Chugtai is a urologist at Weill Cornell Medical College in New York, NY.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.